Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Pradeep Annamalai SubramaniCenter for Global Health and Interdisciplinary Research, College of Public Health, University of South Florida, Tampa, Florida, USA.ORCID 0000-0001-8685-0900
Phornpimon TiptharaMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Surendra Kumar KolliCenter for Global Health and Interdisciplinary Research, College of Public Health, University of South Florida, Tampa, Florida, USA.ORCID 0000-0001-6125-0036
Justin NicholasCenter for Global Health and Interdisciplinary Research, College of Public Health, University of South Florida, Tampa, Florida, USA.
Samantha J BarnesCenter for Global Health and Interdisciplinary Research, College of Public Health, University of South Florida, Tampa, Florida, USA.
Madison M OgbondahCenter for Global Health and Interdisciplinary Research, College of Public Health, University of South Florida, Tampa, Florida, USA.
Kevin C KobylinskiMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.ORCID 0000-0002-4807-9681
Joel TarningMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
John H AdamsCenter for Global Health and Interdisciplinary Research, College of Public Health, University of South Florida, Tampa, Florida, USA.ORCID 0000-0003-3707-7979
Funding
Chemogenomic Profiling of Plasmodium Falciparum Responses and ResistanceR01AI117017 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI ADAMS, JOHN H · 2015 to 2025
$6.9M
Evaluation of ivermectin as an antimalarial therapy against P. falciparum liver stageR21AI149730 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI ADAMS, JOHN H · 2020 to 2021
$361k
HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) R01AI117017HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) R21AI149730NIAID NIH HHS R01 AI117017NIAID NIH HHS R21 AI149730
6 · The paper itself
Abstract
Ivermectin, a broad-spectrum anti-parasitic drug, has been proposed as a novel vector control tool to reduce malaria transmission by mass drug administration. Ivermectin and some metabolites have mosquito-lethal effect, reducing
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Efficacy of ivermectin and its metabolites against · full record | Socratic